SRR934886
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
- sex
- Female
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR934760 | — | — | 0.938 |
| 2 | SRR934881 | — | — | 0.922 |
| 3 | SRR934962 | — | — | 0.910 |
| 4 | SRR934868 | — | — | 0.891 |
| 5 | SRR934753 | — | — | 0.889 |
| 6 | 18E8E3EF-B708-4618-8C89-2F5A9A6A2C9D | — | — | 0.887 |
| 7 | SRR934956 | — | — | 0.877 |
| 8 | SRR934934 | — | — | 0.876 |
| 9 | SRR934864 | — | — | 0.873 |
| 10 | TCGA-70-6722-01A-11R-1820-07 | — | cohortSQ1 | 0.870 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 36 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| ANGIOGENESIS | 0.570 | Remibrutinib | — uncovered |
| EPITHELIAL_MESENCHYMAL_TRANSITION | 0.513 | Inavolisib | — uncovered |
| G2M_CHECKPOINT | 0.510 | Inavolisib | — uncovered |
| E2F_TARGETS | 0.480 | Inavolisib | — uncovered |
| MYC_TARGETS_V1 | 0.423 | Inavolisib | — uncovered |
| WNT_BETA_CATENIN_SIGNALING | 0.374 | Inavolisib | — uncovered |
| TGF_BETA_SIGNALING | 0.365 | Inavolisib | — uncovered |
| INTERFERON_GAMMA_RESPONSE | 0.356 | Idelalisib | — uncovered |
| APOPTOSIS | 0.337 | Idelalisib | — uncovered |
| UNFOLDED_PROTEIN_RESPONSE | 0.337 | Idelalisib | — uncovered |
| ALLOGRAFT_REJECTION | 0.305 | Idelalisib | — uncovered |
| NOTCH_SIGNALING | 0.305 | Inavolisib | — uncovered |
| ANDROGEN_RESPONSE | 0.300 | Inavolisib | — uncovered |
| IL6_JAK_STAT3_SIGNALING | 0.289 | Inavolisib | — uncovered |
| TNFA_SIGNALING_VIA_NFKB | 0.286 | Inavolisib | — uncovered |
| IL2_STAT5_SIGNALING | 0.274 | Idelalisib | — uncovered |
| HEDGEHOG_SIGNALING | 0.273 | Inavolisib | — uncovered |
| MITOTIC_SPINDLE | 0.270 | Inavolisib | — uncovered |
| INTERFERON_ALPHA_RESPONSE | 0.261 | Inavolisib | — uncovered |
| MYC_TARGETS_V2 | 0.256 | Idelalisib | — uncovered |